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The quality of medical care is strongly influenced by the
ontext and systems in which physicians practice (1). The
raditional approaches to address persistent gaps in quality
f care, including education and certification, have failed in
ccomplishing the desired improvements in part because
hese efforts commonly do not address problems embedded
n complex and fragmented systems of care. Importantly,
here are few incentives to modify the status quo and reward
igh performance.
The need to improve the quality of care through systems
mprovements comes at a time of spiraling national health
are costs. Currently, medical care consumes 16% of the
ross domestic product, and experts project that medical
pending will increase to 20% of the gross domestic product
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are will continue to rise because of the rising costs of
ardiac technological advances (3) and the increasing prev-
lence of cardiac disease (4). Therefore, we can expect that
ublic and private payers will increase their focus on both
mproving the quality and efficiency of cardiac care.
Current payment models do little to create a business case
or investing in the systems that will provide reliable,
igh-quality care. Payment is not currently predicated on
erformance except in emerging demonstration projects.
ising overhead costs and declining revenues leave smaller
argins and little incentive to invest in long-term system
mprovements. Traditional models of payment, such as
ee-for-service, may tend to encourage overuse, and man-
ged care arrangements may reward underuse. Payers have
aised questions about the economic motivations of some
ractitioners, while many practitioners note that high-
uality care does not always pay and sometimes can lead to
ess pay. Both payers and providers can agree that a medical
ayment system that consistently encourages and rewards
ppropriate, high-quality care has yet to emerge.
In this setting, many organizations have developed P4P
ilot programs. These programs exist in different economic
arkets throughout the country, and full descriptions of
hese programs are not typically reported in the traditional
edical literature (5–7). Med-Vantage, a health care con-
ulting company with expertise in P4P, lists 115 P4P
rograms on its Web site (8), and Leapfrog, a consortium of
arge businesses, has a compendium of 91 plans of varying
ypes and sizes (9).
This rapid movement toward P4P is occurring despite
ittle experimental or empirical evidence that P4P achieves
ts intended effect in the short or long term (10). There are
ssentially no randomized controlled trials demonstrating
he effectiveness of P4P programs and very few reports in
he literature that analyze the existing programs (5,11–14).
ecause of the lack of health services research and solid
upporting evidence regarding P4P programs, the ACC and
ther organizations (15–18) have developed principles to
uide their members and payers through the transition to
ovel payment mechanisms.
The P4P programs are unlikely to improve patient care
ithout a foundation in valid performance measures. Pro-
essional organizations are a trusted source of scientifically
alid performance measures, and the ACC, along with the
merican Heart Association (AHA), is a leader in setting
rofessional standards for cardiovascular care. The ACC,
ith other organizations, has worked for more than 20 years
o define quality through clinical practice guidelines, per-
ormance measures, appropriateness criteria, and data stan-
ards (19–25). The ACC developed the National Cardio-
ascular Data Registry to help hospitals track and compare
erformance to external benchmarks (26). It sponsored the
uidelines Applied in Practice (GAP) initiatives to dem-
nstrate how guideline recommendations can be more
eliably implemented (27–30). The ACC has worked withhe AHA, the Agency for Healthcare Research and Quality,
he Joint Commission on Accreditation of Healthcare
rganizations, and the Centers for Medicare and Medicaid
ervices to create common national performance measures
or cardiovascular disease, which are critical for the wide-
pread implementation of P4P programs (31). Thus, the
CC is well positioned to provide the professional leader-
hip and guiding principles necessary to design scientifically
alid P4P programs.
The ACC recognizes that P4P programs should inspire
reater focus on improving health care delivery systems. The
CC believes that P4P programs should support and
acilitate the quality improvement process and strengthen
he patient-physician relationship. The P4P programs that
timulate the use of continuous quality improvement meth-
ds can serve to unify multiple participants in the health
are system to improve patient care and realize the full
otential of the American health care system. The P4P
rograms that solely report performance and outcomes
sing outmoded quality assurance methods can be divisive
nd impede a coordinated effort to improve care.
The ACC supports the concept of P4P programs and has
eveloped the following principles to guide the development
f such programs. Physician P4P programs should (be):
1. Built on established evidence-based performance
measures. The P4P programs should be anchored in
valid and reliable measures of performance. The ACC
is a member of the National Quality Forum and
supports the efforts of this and other organizations to
establish valid, reliable, and uniform measures of per-
formance. Measures to be used in the P4P programs
should have the following characteristics:
• Valid. Performance measures used in the P4P pro-
grams should be consistent with those developed by
professional organizations using rigorous methods,
as outlined in “American College of Cardiology and
American Heart Association Methodology for the
Selection and Creation of Performance Measures
for Quantifying the Quality of Cardiovascular Care”
(21). Thus, performance measures should be valid,
evidence-based, interpretable, actionable, reliable,
and feasible.
• Current. Performance process measures used in the
P4P programs should be based on current clinical
practice guidelines and should be rapidly responsive
to changes in guidelines and performance measures
developed by professional organizations. Real-time
performance measures will ensure that payment
policies reflect current science and do not reward
outmoded patterns of care.
• Comparable. Performance measures used in the
P4P programs should provide reliable comparisons
among providers. Performance measures should also
provide reliable longitudinal comparisons for indi-
vidual providers, recognizing that the need for
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performance measures to remain current with ad-
vances in science. In addition, the measures should
be resistant to gaming.
• Risk-Adjusted. Performance measures that assess
outcomes (e.g., mortality) should make necessary
adjustments for patient-level factors such as severity
of illness and comorbidities. The risk-adjustment
methods should be valid and transparent and should
conform to the standards described in the AHA
Scientific Statement on Standards for Statistical
Models Used for Reporting of Public Outcomes
(32). To provide the best assessment of inter-
provider variability in outcomes, the P4P programs
may require the use of specialized analytical ap-
proaches such as hierarchical modeling that account
for clustering and multilevel organization of data.
• Use Standard Data Definitions. Performance should
be measured using available standard data defini-
tions. Using recognized data standards ensures that
the P4P programs are consistent with other data
collection efforts such as clinical trials and disease
registries. This effort for consistency will enable
comparisons among data sources and reduce the
cost of data collection in institutions that are col-
lecting data for multiple purposes. Where applica-
ble, ACC/AHA Clinical Data Standards should be
used (24,25).
2. Create a business case for investing in structure,
best practices, and tools that can lead to improve-
ment and high-quality care. The P4P programs must
seek to create a sustainable business case for quality by
recognizing the true resource costs associated with
achieving and maintaining high-quality care. Informa-
tion technology systems must be in place in order to
capture and report performance; therefore, the P4P
programs should provide adequate margins over cost to
create incentives for practitioners to invest in infra-
structure and overcome overhead expenses, such as staff
time, training, process change and technology hard-
ware, software, and licensing fees. Inadequately ac-
counting for the overhead costs will result in inade-
quate profit margins, insufficient incentives, and
unsustainable programs.
• Structure. Implementing quality improvement sys-
tems requires substantial initial capital investments.
The P4P programs should yield an adequate direct
return on investment over a reasonable timeframe.
Data Collection. Collecting the data to drive a P4P
program is costly. Generating data through partic-
ipation in registries, maintenance of electronic
health records, performing chart reviews, or from
other sources requires equipment and staffing and
generates ongoing expenses.Organizational Structure. Whether hospital- or
practice-based, the P4P program participants will
need to convene groups of committed individuals to
internally analyze performance data and to monitor
continuous quality improvement efforts. In hospi-
tals, this effort extends beyond routine medical staff
responsibilities and should be rewarded through
direct or indirect financial incentives. Such incen-
tives should encourage physicians to participate in
committees, monitor data collection, actively partic-
ipate in data analysis, and work with hospital
administration to create action plans that will result
in continuous quality improvement. Shared ac-
countability for quality should be matched with
shared rewards.
• Best Practices. Ideal P4P programs should promote
regional collaboration. Payers, in collaboration with
physician organizations, should encourage and sup-
port the exchange of best practices, giving all par-
ticipants maximum opportunity to improve. Pro-
grams should consider providing additional
incentives to physicians who champion regional
quality improvement programs.
Benchmarking. Benchmarking is an essential feature
of data analysis and improvement. It is important
for practices and institutions to have reliable and
objective benchmarking against which to compare
their performance. The ACC National Cardiovas-
cular Data Registry provides a mechanism to bench-
mark performance of cardiac procedures. This reg-
istry and other databases are important resources for
hospitals seeking to compare their performance to
external benchmarks for the purpose of gauging
performance and improvement. The P4P programs
should encourage participation in national disease
registries that allow for external benchmarking.
Tools. The ACC’s GAP initiative, the AHA’s Get
With The Guidelines initiative, and others have
developed tools and strategies for quality improve-
ment. Standing orders, discharge instructions, and
care management plans are examples of tools that
can support improvement. The P4P programs
should encourage participation in these types of
programs, and should encourage the uptake of tools
and strategies that facilitate improvement.
3. Reward process, outcome, improvement and sus-
tained high performance.
• Process. Measuring processes of care (e.g., provision
of evidence-based medications to eligible patients)
offers the best opportunity to improve the quality of
care and focus attention on improvement. The P4P
programs that focus on process may be particularly
important in the ambulatory care setting, where
outcomes that result from those processes may not
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difficult to attribute to a specific provider.
• Outcome. Ultimately, patients care most about the
results of their care and outcomes measurement can
complement the more narrowly focused process
measurement. Physicians can improve patient out-
comes through interventions and medical manage-
ment, but outcome measures are also influenced by
patient factors such as disease severity, comorbidi-
ties, and patient adherence. Therefore, outcome
measures are not completely under the physician’s
control, and use of outcome measures requires
proper risk-adjustment. Also, the P4P programs
that use outcome measures may need to use ad-
vanced methodological strategies such as hierarchi-
cal modeling for proper analysis of performance
data. In addition, because outcome measures are
also dependent on patient compliance, the P4P
programs should consider the concomitant use of
patient incentives to encourage patient participation
and compliance.
• Improvement and Sustained High Performance.
The P4P programs should seek to reward programs
and practitioners who show substantial improve-
ment as well as those who are able to achieve and
sustain high levels of performance. Limiting re-
wards to improvement alone creates a ceiling effect
for providers who start at or achieve high levels of
performance. On the other hand, limiting rewards
to threshold levels of achievement would discourage
providers who start at low levels from attempting to
participate, perhaps exacerbating current disparities
in care. Ideal P4P programs will reward participants
who show substantial improvement, as well as
participants who sustain high levels of performance.
4. Assign attribution of credit for performance to
physicians in ways that are credible and encourage
collaboration. It is often difficult to attribute a specific
outcome measure to a specific physician or physician-
group and these issues must also be addressed in any
program. In general, the P4P programs should be
based on aggregate performance data (e.g., by practice
group or hospital affiliation) rather than individual
physician-level measurement to avoid statistical limi-
tations related to small populations, to engender co-
operative team approaches, and to create shared ac-
countability. Incentives should be structured to
encourage collaboration between physician-groups, es-
pecially between specialty and primary care groups. It
may be possible to use process measures to evaluate
individual providers, but using outcomes measures
may create difficulties in attributing accountability.
Programs should attempt to overcome difficulties in
assigning attribution through designs that createshared accountability and reward based on aggregate
performance.
5. Favor the use of clinical data over administrative
claims data. In general, administrative claims data
sources will always raise questions and concerns re-
garding validity and reliability, although there may be
some exceptions, such as pharmacy claims data or
laboratory data. Administrative data sources usually do
not supply adequate information about patient at-
tributes or the care setting to properly adjust for risk or
to adequately exclude inappropriate patients from the
data set.
• Physician Review and Correction. The P4P pro-
grams should include a mechanism to allow for
physician review and correction of data, particularly
administrative data, before the data are used to
determine performance levels and levels of reward.
Physicians should be allowed to supplement or
correct data deficiencies without the need for oner-
ous appeals processes.
• Validation. If administrative data sets are used for
the P4P programs, they should be validated against
a reliable source of clinical data. This validation can
occur at the level of the data element or at the level
of the result such that the inference from the
administrative data source is shown to be similar to
that from a clinical data source. Only data sources
with a low misclassification rate should be used for
the P4P programs.
6. Set targets for performance through a national
consensus process. The P4P programs will require not
only valid performance measures, but also will require
reasonable and achievable targets or thresholds of
performance to determine rewards. The P4P programs
should set achievable targets through a realistic evalu-
ation of current performance using benchmarks ob-
tained from national databases. Furthermore, target
levels should not create a disadvantage for participants
that are starting from low starting points because they
serve disadvantaged socioeconomic populations or be-
cause of baseline resource constraints.
7. Address appropriateness. The P4P programs should
address not only what should be done and rewarded,
but what should not be done and not rewarded; that is,
there should be explicit consideration of what behav-
iors are to be discouraged as well as what behaviors are
to be encouraged. These decisions should be based on
solid clinical evidence and consensus statements such as
the appropriateness criteria recently developed by the
ACC and the American Society of Nuclear Cardiology
(22,23). Where there is not sufficient evidence to deter-
mine appropriateness, clinical studies should be encour-
aged to determine the appropriate standard of care.
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emphasize success and reward achievement. The P4P
rewards should be funded through the cost savings that
health plans may realize from the P4P programs, and
not by shifting revenue from low performing providers.
Taking funds from one group of providers to pay
another group could have the unintended consequence
of creating further resource restraints on providers who
most need the resources to improve.
• Patterns of Care. The P4P participants should be
rewarded on the basis of patterns of care, not
case-by-case specific care. The P4P programs
should be based on a quality improvement model—
looking at patterns of care across populations—as
compared with a quality assurance model, which
looks at care on a case-by-case basis. Improving the
aggregate quality of care, including efficiency,
should be the goal, rather than attempting to
eliminate outliers.
• Local Resource Constraints. Certain P4P program
participants and some communities may have socio-
economic disadvantages, limited access to technol-
ogy, and other local resource constraints. The P4P
programs should attempt to avoid the unintended
consequences of penalizing disadvantaged partici-
pants and should recognize that providing incen-
tives for such participants may provide the best
opportunity to improve overall quality of care.
• Efficient Targeting of Resources. Efforts should be
made to reward efficiency in improving care for
populations of patients. Consideration should be
given toward preferentially rewarding care teams,
disease management programs, and programs that
target populations most in need and who have the
highest chance for marginal improvement.
9. Audit performance measure data. The data used for
the P4P-based programs should be submitted to an
objective third party for periodic auditing. Mechanisms
should be established to allow the P4P participants
themselves to audit the performance data. The P4P
programs should consider using the model of some
disease registries such as ACC’s National Cardiovas-
cular Data Registry, which includes an auditing com-
ponent and standardized quarterly reports for feedback
to providers.
0. Establish transparent provider rating methods. The
provider rating method, including detailed measure-
ment specifications and algorithms used to combine
scores from individual measures and/or group provid-
ers into performance tiers, should be publicly disclosed.
Such disclosures recognize that there may be variations
in the methods by which entities transform results
from provider performance measurement into provider
ratings based on differences in populations, care inter-
ventions by third parties (e.g., disease managementorganizations), performance incentives, negotiated
rates, and other considerations. Measurement program
rules should be clearly delineated and disseminated
prior to implementation. Furthermore, prior to imple-
mentation, plans should seek the participation of
physician groups to ensure “buy-in,” participation, and
successful implementation of these programs. If data
are to be reported publicly, reporting entities should
adhere to principles such as those outlined in the AHA
Scientific Statement on Standards for Statistical Mod-
els Used for Reporting of Public Outcomes (32).
1. Not create perverse incentives. The P4P programs
have the potential to create perverse incentives such as
adverse selection, gaming, and treating the metric,
rather than treating the patient. The P4P programs
should recognize the potential for perverse incentives
and should be vigilant and ready to correct any design
flaws that have unintended consequences.
2. Invest in outcomes and health services research. The
ACC recognizes that there are areas in which the
evidence base is inadequate or for which accurate
performance measurement is not feasible. These areas
may be unsuitable for quality-based reimbursement at
this time. The ACC encourages investment and par-
ticipation in data collection efforts that enable analysis
of the relationship between processes and outcomes
and, thus, shed light on how to optimize care in those
uncertain areas. In addition, there should be support of
implementation research, that is, the study of the P4P
itself, including its efficacy and safety.
• Evaluation and Assessment. The P4P programs
should undergo periodic assessments to test for in-
tended and unintended impacts on access, costs, qual-
ity, health outcomes, and physician and patient satis-
faction. Further research should attempt to assess the
implications of the P4P and compare P4P programs
with other quality improvement approaches.
The P4P programs will introduce new payment models
hat have the potential to create better alignment of incen-
ives. Aligned incentives could result in improvement in the
uality and efficiency of medical care. The P4P programs
hat adhere to the principles presented here will have a
reater chance of achieving their intended purpose.
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ohn E. Brush, Jr., MD, FACC None None None None
arlan M. Krumholz, MD, SM, FACC ● CMS None None ● United Health Group
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